• Journal of Chest Surgery
• /
• 제30권3호
• /
• pp.247-252
• /
• 1997

Ten acute and chronic in vivo studies were utilized to develop a pneumatic ventricular assist device (VAD) as a bridge to heart transplantation or a circulatory assist device for patients with end-stage heart disease or poor myocardial funct on after cardiac surgery. Two sizes of blood pump of 70cc for adult patients and 34cc for pediatric patients were implanted in the animals. Ventricle of the blood pump was made from the polyurethaae to enhance antithrombogenecity. The VAD was implanted between the left atrium and the descending aorta. Average flow rate was 2.38 L/min for adult and 0.41 L/min for pediatric VAD at the rate of 60 bum. The duration of support ranged from 1 to 26 hours. The most frequent complication was bleeding. Main causes of death were heart failure and respiratory failure. The device function was good for short term use. Studies to date suggest that, with further refinement, a reliable long term VAD that will have clinical application can be developed.

• Journal of Biomedical Engineering Research
• /
• 제25권1호
• /
• pp.65-70
• /
• 2004

In this paper, we described 23 cases of animal experiment with our pneumatic ventricular assist device and new durability-improvement method. The blood pump consists of blood housing, and back plate made by the injection molding of isoplast, and the diaphragm fabricated by dipping of polyurethane solution onto the aluminum mold. Its volume was 75 $m\ell$ and in-vitro test showed that maximum output was 4.5 $\ell$/min at the 100 mmHg. The adult female sheep with weight of 50 ＋ 10 kg were employed for tile in-vivo experiments and the mean blood flow was sustained at 3.0 1/min. 4 animals survived more than 15 days and the longest survival time was 28 days. In the prior 10 cases, the major causes of death were the tearing of diaphragm at the diaphragm to blood housing junction. By the new mesh and alumina ball milling methods, the durability was enhanced, and its qualitative and quantitative improvement was proved via the in-vivo and in-vitro methods. Animal experiments demonstrated that all the physiologic parameters a ere maintained within the permissible ranges and no thrombus formation was observed through the visual and blood test. The in-vivo experiments demonstrated our pneumatic ventricular assist device to he one month's bridge to transplantation device.

• Nuclear Engineering and Technology
• /
• 제34권5호
• /
• pp.468-481
• /
• 2002

There are 4 CANDU6 type reactors operating at Wolsong site. For fuelling operation of certain fuel channels (with flow less than 21.5 kg/s) a FARE flow Assist Ram Extension) device is used. During the refuelling operation, two remote controlled F/Ms (Fuelling Machines) are attached to a designated fuel channel and carry out refuelling job. The upstream F/M inserts new fuel bundles into the fuel channel while the downstream F/M discharges spent fuel bundles. In order to assist fuelling operation of channels that has lower coolant How rate, the FARE device is used instead of F/M C-ram to push the fuel bundle string. The FARE device is essentially a How restricting element that produces enough drag force to push the fuel bundle string toward downstream F/M. Channels that require the use of FARE device for refuelling are located along the outside perimeter of reactor. This paper presents the FARE device design feature, steady state hydraulic and operational characteristics and behavior of the device when coupled with fuel bundle string during fuelling operation. The study showed that the steady state performance of FARE device meets the design objective that was confirmed by downstream F/M C-ram force to be positive.

• Journal of Chest Surgery
• /
• 제34권5호
• /
• pp.403-406
• /
• 2001

본 증례는 66세(51.8kg)된 남자에서 수술전 심한 좌심실 기능 부전과 승모판 및 삼첨판 폐쇄부전이 있어 개심술 시행후 심한 저심박출증 발생으로 인공심폐기 이탈에서 실패하고 양심실 보조장치(Centrifugal Biopump)를 사용한 후 이로부터 성공적인 이탈과 퇴원이 보고하는 바이다.

• Journal of Chest Surgery
• /
• 제27권5호
• /
• pp.390-393
• /
• 1994

의료기술의 발달로 오늘날의 개심술은 대부분 성공적으로 시행되고 있지만 극히 일부분은 아직도 개심술후 심한 심실기능의 저하로 사망하는 겨우가 있다. 1960년대 중반 Spencer와 DeBakey에 의해 개심술후 심한 심실기능이 저하된 환자에게 심실보조장치를 이용하여 성공적으로 치험한 이후로 많은 발전을 거듭해 왔다. 저자들은 4개월 (6.5Kg)된 남아에서 개심술후 심한 저심박출증으로 인공심폐기의 제거를 못하여 좌심실 보조장치(Centrifugal Biopump)를 사용하여 성공적으로 치험하였기에 보고하는 바이다.

• The Journal of the Convergence on Culture Technology
• /
• 제9권2호
• /
• pp.525-531
• /
• 2023

In Korea, which is entering a super-aged society, the number of elderly patients who have difficulty walking independently is expected to increase rapidly, and it is necessary to develop wheelchair products with various functions to improve the quality of life of people with walking disabilities. Recently, wheelchair power assist devices that provide propulsion power by being attached to a manual wheelchair has been developed and is entering the domestic and global markets. In this study, we compared and analyzed the process of obtaining medical device certification for wheelchair power assist devices in Korea, the United States, and Europe. In Korea, a Class 2 medical device certification process was developed in 2021, and in the US FDA, it corresponds to Class 2 like the existing electric wheelchair and must pass the 510k certification process. In the case of Europe, it is uniquely regulated as Class I, and the CE mark can be attached through a relatively easy self-declaration of conformity. The Korean medical device industry, which is struggling with MDR certification, a new European medical device regulation, should pay attention to the relatively easy entry into the global market for wheelchair power assist products.

• Journal of rehabilitation welfare engineering & assistive technology
• /
• 제8권2호
• /
• pp.79-88
• /
• 2014

In Republic of Korea, there are considerable vulnerability in electrical stimulating swallowing-assist equipments even though they are professional medical equipments and have high penetration rate with heavy frequency of use. Therefore, in this article, we developed Device Management and Safety Diagnosis Manual for Electrical Stimulating Swallowing-Assist Equipments system. For achieving this, we collected and analysed international standard data from international organizations like International Electrotechnical Commission(IEC). After literature reviews, we build maintenance worksheet and equipment procedure manual for electrical stimulating swallowing-assist equipments according to evidences we collected. These manual and protocol would be used as standard process and contribute to sustain accuracy, effectiveness of the devices, also decrease failure rate and assist to save medical documents.

• Journal of Chest Surgery
• /
• 제48권6호
• /
• pp.407-410
• /
• 2015

A two-month-old infant presented with coarctation of the aorta, severe left ventricular dysfunction, and moderate to severe mitral regurgitation. Through median sternotomy, the aortic arch was repaired under cardiopulmonary bypass and regional cerebral perfusion. The patient was postoperatively supported with a left ventricular assist device for five days. Left ventricular function gradually improved, eventually recovering with the concomitant regression of mitral regurgitation. Prompt surgical repair of coarctation of the aorta is indicated for patients with severe left ventricular dysfunction. A central approach for surgical repair with a back-up left ventricular assist device is a safe and effective treatment strategy for these patients.

• Journal of Biomedical Engineering Research
• /
• 제23권1호
• /
• pp.33-38
• /
• 2002

A Ventricular Assist Device(YAD) is used to support the injured natural heart So. when considering a control algorithm for YAD. it is important to reduce a natural heart's load to enhance its recovery condition. To reduce natural heart's load, a counterpulsation algorithm is used commonly. In this study, we developed a counterpulsation control algorithm for moving-actuator type VAD and tested its usefulness using in vitro MOCK circulatory system. To notice a natural heart's Pumping status, electrocardiogram(ECG) signal was used and as a result of test. the counterpulsation effect between YAD and a natural heart was occurred and Automatic Control Mode Transition was occurred properly.

• Journal of Biomedical Engineering Research
• /
• 제19권1호
• /
• pp.39-46
• /
• 1998

In this paper, we present a neural network identification and a control of highly complicated nonlinear left ventricular assist device(LVAD) system with a pneumatically driven mock circulation system. Generally, the LVAD system needs to compensate for nonlinearities. It is necessary to apply high performance control techniques. Fortunately, the neural network can be applied to control of a nonlinear dynamic system by learning capability. In this study, we identify the LVAD system with neural network identification(NNI). Once the NNI has learned the dynamic model of the LVAD system, the other network, called neural network controller(NNC), is designed for a control of the LVAD system. The ability and effectiveness of identifying and controlling the LVAD system using the proposed algorithm will be demonstrated by computer simulation.